Syndax Pharmaceuticals, Inc.SNDXNASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, above historical average, strong compound growth.
Left:
||||
Year-over-year net income growth rate
Latest
-52.25%
↑ 37% above average
Average (9y)
-82.81%
Historical baseline
Range
High:134.11%
Low:-699.13%
CAGR
+10.3%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | -52.25% |
| 2023 | -40.19% |
| 2022 | -699.13% |
| 2021 | 134.11% |
| 2020 | -30.59% |
| 2019 | 24.35% |
| 2018 | -21.64% |
| 2017 | -36.72% |
| 2016 | -84.39% |
| 2015 | -21.64% |